Skip to main content
Nexphoria

Compound Tag

NMN / NR / NAD+ Precursors

4 research articles in this compound library

Longevity9 min read

NAD+ Precursors in Research: NMN vs NR vs Direct NAD+ Injection

A pharmacological deep dive into the three main NAD+ replenishment strategies used in preclinical research — NMN, NR, and direct injectable NAD+. Covers intracellular conversion pathways, bioavailability differences, published rodent dose data, the Slc12a8 transporter controversy, methylation burden considerations, and which form to use for which research question.

May 29, 2026Read
Longevity9 min read

NAD+ Research Protocols: Dosing, Routes, and Study Design

A practical research guide covering NAD+ and precursor dosing protocols — injectable vs oral vs IV forms, published rodent dose-response data, reconstitution protocol, light sensitivity, sirtuin activation endpoints, NAMPT inhibition controls, and four critical study design considerations.

May 29, 2026Read
Longevity10 min read

Peptide Stacking for Longevity: NAD+, Epitalon, SS-31, and GHK-Cu

A mechanistic deep dive into the four-compound longevity research stack: NAD+ (sirtuin/mitochondrial biogenesis), Epitalon (telomerase/melatonin), SS-31 (cardiolipin/mitochondrial ETC), and GHK-Cu (Nrf2/collagen/gene expression). Covers synergy rationale, full factorial study design, endpoint selection, dosing protocols, and research design considerations.

May 29, 2026Read
Compound Profiles9 min read

NAD+: Cellular Energy, Sirtuins, and Longevity Research

A deep dive into NAD+ as a research compound — covering its role as a redox coenzyme, the NAMPT salvage pathway, sirtuin and PARP activation, mitochondrial biogenesis via PGC-1alpha, and a critical comparison of NR, NMN, and IV NAD+ in published research.

May 28, 2026Read
All Research Articles

Research Catalog

Ready to source?

Browse the Catalog

RUOFor Research Use Only (RUO) — Not for human consumption, clinical use, diagnostic use, or veterinary applications.